It has been reported that polyclonal antibodies prepared using the extracellular segment of SDC4 (N93-V121) as the antigen achieved the same relief as knocking down SDC4 in experimental asthma and rheumatoid arthritis [21, 22]. Here, SDC4 is linked to asthma.